Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis.
Riedell PA, Grady CB, Nastoupil LJ, Luna De Abia A, Ahmed N, Maziarz RT, Hu M, Brower J, Hwang WT, Schuster SJ, Chen AI, Oluwole OO, Bachanova V, McGuirk JP, Perales MA, Bishop MR, Porter DL.
Riedell PA, et al. Among authors: chen ai.
Blood Adv. 2024 Dec 10:bloodadvances.2024014164. doi: 10.1182/bloodadvances.2024014164. Online ahead of print.
Blood Adv. 2024.
PMID: 39657136